课题基金 / 基金详情

Elucidating The Roles of PIK3IP1/TrIP Regulation on Distinct T Cell Subsets in the Context of Cancer

Elucidating The Roles of PIK3IP1/TrIP Regulation on Distinct T Cell Subsets in the Context of Cancer
阐明 PIK3IP1/TrIP 对癌症中不同 T 细胞亚群的调节作用
批准号:
10624221
负责人:
Benjamin Murter
金额:
$4.77万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-02-01 至 2024-05-31

项目摘要

项目成果

Benjamin Murter的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 磷脂酰肌醇-3-激酶(PI 3 Ks)信号通路是一种高度保守和严格调控的信号通路 影响所有细胞类型的活化、增殖和存活。PI 3 K信号在T细胞中起着重要作用 由于其位置直接位于T细胞受体(TCR)/CD 28连接的下游,因此对抗原产生应答。我们的实验室 最近显示,细胞表面蛋白TrIP(PI 3 K的跨膜抑制剂,基因名称:Pik 3 ip 1)具有与细胞表面蛋白TrIP(PI 3 K的跨膜抑制剂,基因名称:Pik 3 ip 1)相同的生物学活性。 在T细胞上明显高表达,并且能够下调CD 4 + T细胞中的PI 3 K信号传导, T细胞免疫反应的负调节因子。这些研究表明,缺乏TrIP的CD 4 + T细胞 在体内和体外,与WT对照相比,表达的小鼠表现出更多的Th 1炎性表型。这些 数据使我们提出TrIP限制了CD 8 + T细胞的炎症活性, 靶向/敲除该负调节因子可以促进抗肿瘤免疫。我已经得到 初步数据表明,CD 8 + T细胞特异性TrIP敲除小鼠(TrIPf 1/flE 8icre)对生长有抗性, 同基因肿瘤除了增加的肿瘤抵抗力,我们还发现, 我们的TrIPf 1/f1 E8 icre敲除小鼠含有的浸润性T细胞是其WT对应物的两倍。我们 还发现CD 8 + T细胞是这种增加的T细胞浸润的主要驱动力,因为它们的频率是 是CD 4+细胞的两倍。这些初步数据是我们旨在进一步 阐明TrIP活性在CD 8 + T细胞中的细胞内在效应,包括其对抗肿瘤免疫的影响。这些 这些研究不仅将提高我们对TrIP作为负性免疫调节剂的理解,而且还将提供有关 TrIP作为未来免疫靶点的潜力。
英文摘要
PROJECT SUMMARY The signaling pathways involving phosphoinositide-3-kinases (PI3Ks) are highly conserved and tightly regulated to influence the activation, proliferation, and survival of all cell types. PI3K signaling plays a major role in T cell responses to antigen due to its position directly downstream of T cell receptor (TCR)/CD28 ligation. Our lab has recently shown that the cell surface protein TrIP (Transmembrane Inhibitor of PI3K, gene name: Pik3ip1) has a distinctly high expression on T cells and is capable of downregulating PI3K signaling in CD4+ T cells, acting as a negative regulator of T cell immune responses. These studies revealed that CD4+ T cells lacking TrIP expression exhibit a more Th1 inflammatory phenotype compared to WT controls both in vivo and in vitro. These data have led us to propose that TrIP restricts the inflammatory activity of CD8+ T cells, and that targeting/knockout of this negative regulator may promote anti-tumor immunity. I have already obtained preliminary data demonstrating that CD8+ T cell-specific TrIP knockout mice (TrIPfl/flE8icre) are resistant to growth of syngeneic tumors. In addition to increased tumor resistance, we have also found that tumors harvested from our TrIPfl/flE8icre knockout mice contain twice as many infiltrating T cells compared to their WT counterparts. We also found that CD8+ T cells were the main drivers of this increased T cell infiltration, as their frequency was double that of the CD4+ population. These preliminary data are the basis of our proposal aimed at further elucidating cell-intrinsic effects of TrIP activity in CD8+ T cells, including its impact on antitumor immunity. These studies will not only improve our understanding of TrIP as a negative immune regulator, but also inform on the potential for TrIP as a future immunotherapeutic target.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating The Roles of PIK3IP1/TrIP Regulation on Distinct T Cell Subsets in the Context of Cancer
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究